Product Description: Oloctinebart is a humanized immunoglobulin G4-kappa, anti-LGALS3 monoclonal antibody. Oloctinebart is used for reduction of amyloid beta oligomers formation[1].
Applications: Neuroscience-Neuromodulation
Formula: N/A
References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 4, 2022.
CAS Number: 2669063-84-5
Molecular Weight: N/A
Research Area: Neurological Disease
Solubility: 10 mM in DMSO
Target: Others